RT Journal Article
T1 Acute heart failure and adverse events associated with the presence of renal dysfunction and hyperkalaemia. EAHFE- renal dysfunction and hyperkalaemia.
A1 Jacob, Javier
A1 Llauger, Lluis
A1 Herrero-Puente, Pablo
A1 Martín-Sánchez, Francisco Javier
A1 Llorens, Pere
A1 Roset, Alex
A1 Gil, Victor
A1 Fuentes, Marta
A1 Lucas-Imbernón, Francisco Javier
A1 Miró, Òscar
A1 ICASEMES-Research Group, 
K1 Acute heart failure
K1 Hyperkalaemia
K1 Outcomes
K1 Renal dysfunction
AB To study the outcomes of patients with acute heart failure (AHF) presenting renal dysfunction (RD) or hyperkalaemia (Hk) alone or in combination. We analysed the data of the EAHFE registry, a multicentre, non interventionist cohort with prospective follow-up of patients with AHF. Four groups were defined based on the presence or not of RD or Hk alone or in combination. The primary endpoint was 30-day all-cause mortality. A total of 11,935 of the 13,791 patients included in the EAHFE registry were analysed. Of these, 5088 (42.6%) did not have RD or Hk (NoRD-NoHk), 150 (1.3%) had no RD but had Hk (NoRD-Hk), 6012 (50.4%) had RD but not Hk (RD-NoHk) and 685 (5.7%) had both RD and Hk (RD-Hk). Thirty-day all-cause mortality was greatest in the RD-Hk group with an adjusted Hazard Ratio (HR) of 2.44 (confidence interval 95% [CI95%] 1.67-3.55; p  The association of 30-day all-cause mortality with the presence of RD and Hk in patients presenting AHF at admission is greater than in those without this combination.
YR 2019
FD 2019-07-20
LK http://hdl.handle.net/10668/14280
UL http://hdl.handle.net/10668/14280
LA en
DS RISalud
RD Apr 7, 2025